Analysts See More Upside For Sarepta Therapeutics
May 20, 2015 at 16:48 PM EDT
Sarepta Therapeutics Inc(NASDAQ: SRPT) gained more than 60 percent Wednesday on news that it expects to complete an approval ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.